paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | DISCUSSION | 0 | null | null | 20,808,590 | null | However, further study on the two surgical procedures, such as a long term follow-up and a comparison, is needed. | null | 113 | 43,919 | 0 | false | null | null | However, further study on the two surgical procedures, such as a long term follow-up and a comparison, is needed. | true | true | true | true | true | 7,592 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Intractable neuropathic pain often results from peripheral nerve injury or abnormal changes in the central nervous system caused by trauma, surgery, compression injuries, infection, metabolic diseases, ischemic or vascular diseases, immune diseases, or toxins [1,2]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 266 | 43,920 | 0 | false | Intractable neuropathic pain often results from peripheral nerve injury or abnormal changes in the central nervous system caused by trauma, surgery, compression injuries, infection, metabolic diseases, ischemic or vascular diseases, immune diseases, or toxins. | [
"1,2"
] | Intractable neuropathic pain often results from peripheral nerve injury or abnormal changes in the central nervous system caused by trauma, surgery, compression injuries, infection, metabolic diseases, ischemic or vascular diseases, immune diseases, or toxins. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Because such neuropathic pain is difficult to treat, prevention is considered the most effective treatment strategy. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 116 | 43,921 | 0 | false | Because such neuropathic pain is difficult to treat, prevention is considered the most effective treatment strategy. | [] | Because such neuropathic pain is difficult to treat, prevention is considered the most effective treatment strategy. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | This process involves the administration of local anesthetics, opioids, and nonsteroidal anti-inflammatory drugs, glucocorticoids, alone or in combination, via local, epidural, intrathecal, or systemic routes [3,4]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 215 | 43,922 | 0 | false | This process involves the administration of local anesthetics, opioids, and nonsteroidal anti-inflammatory drugs, glucocorticoids, alone or in combination, via local, epidural, intrathecal, or systemic routes. | [
"3,4"
] | This process involves the administration of local anesthetics, opioids, and nonsteroidal anti-inflammatory drugs, glucocorticoids, alone or in combination, via local, epidural, intrathecal, or systemic routes. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Research has shown that this form of analgesia reduces pain and morbidity, minimizing analgesic requirements, and resulting in shorter hospitalizations [5-7]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 158 | 43,923 | 0 | false | Research has shown that this form of analgesia reduces pain and morbidity, minimizing analgesic requirements, and resulting in shorter hospitalizations. | [
"5-7"
] | Research has shown that this form of analgesia reduces pain and morbidity, minimizing analgesic requirements, and resulting in shorter hospitalizations. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | However, some studies have failed to detect a difference between pre- and post-operative treatment groups with respect to preemptive analgesia | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 142 | 43,924 | 0 | false | However, some studies have failed to detect a difference between pre- and post-operative treatment groups with respect to preemptive analgesia | [] | However, some studies have failed to detect a difference between pre- and post-operative treatment groups with respect to preemptive analgesia | true | true | false | true | false | 7,593 |
0 | INTRODUCTION | 1 | 11 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Several studies have shown that perioperatively administered glucocorticoids have strong anti-inflammatory effects, reducing pain and swelling after oral surgery [11], orthopedic surgery, spinal surgery [12] and laparoscopic surgery [13]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 238 | 43,925 | 1 | false | Several studies have shown that perioperatively administered glucocorticoids have strong anti-inflammatory effects, reducing pain and swelling after oral surgery, orthopedic surgery, spinal surgery and laparoscopic surgery. | [
"11",
"12",
"13"
] | Several studies have shown that perioperatively administered glucocorticoids have strong anti-inflammatory effects, reducing pain and swelling after oral surgery, orthopedic surgery, spinal surgery and laparoscopic surgery. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Dexamethasone has long-acting (several days) effects that would appear to make it an ideal drug to combine with preemptive analgesia. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 133 | 43,926 | 0 | false | Dexamethasone has long-acting (several days) effects that would appear to make it an ideal drug to combine with preemptive analgesia. | [] | Dexamethasone has long-acting (several days) effects that would appear to make it an ideal drug to combine with preemptive analgesia. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Dexamethasone-containing bupivacaine microspheres may prolong the duration of nerve block in animal and human studies [14-16]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 126 | 43,927 | 0 | false | Dexamethasone-containing bupivacaine microspheres may prolong the duration of nerve block in animal and human studies. | [
"14-16"
] | Dexamethasone-containing bupivacaine microspheres may prolong the duration of nerve block in animal and human studies. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 17 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | It has also been shown that adding methylprednisolone to local anesthetic may increase the duration of axillary brachial block [17]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 132 | 43,928 | 1 | false | It has also been shown that adding methylprednisolone to local anesthetic may increase the duration of axillary brachial block. | [
"17"
] | It has also been shown that adding methylprednisolone to local anesthetic may increase the duration of axillary brachial block. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | In addition, Kelly et al. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 25 | 43,929 | 0 | false | In addition, Kelly et al. | [] | In addition, Kelly et al. | true | true | true | true | true | 7,593 |
0 | INTRODUCTION | 1 | 18 | [
"B1",
"B2",
"B3",
"B4",
"B5",
"B7",
"B8",
"B10",
"B11",
"B12",
"B13",
"B14",
"B16",
"B17",
"B18"
] | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | insisted that preemptive analgesia could be achieved using continuous or intermittent administration of single analgesics or analgesic combinations and treatment strategies that targeted the periphery, inputs along sensory axons, or central nervous system (CNS) sites [18]. | [
"1",
"2",
"3",
"4",
"5",
"7",
"8",
"10",
"11",
"12",
"13",
"14",
"16",
"17",
"18"
] | 273 | 43,930 | 1 | false | insisted that preemptive analgesia could be achieved using continuous or intermittent administration of single analgesics or analgesic combinations and treatment strategies that targeted the periphery, inputs along sensory axons, or central nervous system (CNS) sites. | [
"18"
] | insisted that preemptive analgesia could be achieved using continuous or intermittent administration of single analgesics or analgesic combinations and treatment strategies that targeted the periphery, inputs along sensory axons, or central nervous system (CNS) sites. | false | true | true | true | false | 7,593 |
1 | INTRODUCTION | 0 | null | null | 20,830,261 | pmid-1589245|pmid-2812843|pmid-6656869|pmid-7104735 | Therefore, the aim of this study was to test whether the combination of dexamethasone and local anesthetics increases the preemptive analgesic effect of local anesthetics in the spared nerve injury model. | null | 204 | 43,931 | 0 | false | null | null | Therefore, the aim of this study was to test whether the combination of dexamethasone and local anesthetics increases the preemptive analgesic effect of local anesthetics in the spared nerve injury model. | true | true | true | true | true | 7,594 |
0 | DISCUSSION | 0 | null | null | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | In this study, perineural infiltration with 0.8 mg dexamethasone and 0.4% bupivacaine (0.2 ml) prior to surgery prevented the development of mechanical allodynia through POD 21. | null | 177 | 43,932 | 0 | false | null | null | In this study, perineural infiltration with 0.8 mg dexamethasone and 0.4% bupivacaine (0.2 ml) prior to surgery prevented the development of mechanical allodynia through POD 21. | true | true | true | true | true | 7,595 |
0 | DISCUSSION | 0 | null | null | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | In the group infiltrated with bupivacaine alone, mechanical allodynia developed early but gradually decreased after POD 9. | null | 122 | 43,933 | 0 | false | null | null | In the group infiltrated with bupivacaine alone, mechanical allodynia developed early but gradually decreased after POD 9. | true | true | true | true | true | 7,595 |
0 | DISCUSSION | 0 | null | null | 20,830,261 | pmid-10371588|pmid-1370574|pmid-16946657|pmid-11840097|pmid-8499204|pmid-12045850|pmid-8198905|pmid-1637601|pmid-7042372|pmid-12437261|pmid-14578725|pmid-8916834|pmid-12538215|pmid-15305267|pmid-11698320 | Dexamethasone alone had no effect on the development of mechanical allodynia. | null | 77 | 43,934 | 0 | false | null | null | Dexamethasone alone had no effect on the development of mechanical allodynia. | true | true | true | true | true | 7,595 |
1 | DISCUSSION | 1 | 21 | [
"B21",
"B22",
"B23",
"B24"
] | 20,830,261 | pmid-1589245|pmid-2812843|pmid-6656869|pmid-7104735 | Neuropathic pain can develop through various mechanisms, such as a large increase in spontaneous (ectopic) discharges in dorsal root ganglia cell bodies and injured afferent fibers [21], cross excitation, damage to the high-threshold nociceptors (peripheral sensitization), collateral sprouting of intact fibers into den... | [
"21",
"22",
"23",
"24"
] | 344 | 43,935 | 1 | false | Neuropathic pain can develop through various mechanisms, such as a large increase in spontaneous (ectopic) discharges in dorsal root ganglia cell bodies and injured afferent fibers, cross excitation, damage to the high-threshold nociceptors (peripheral sensitization), collateral sprouting of intact fibers into denervat... | [
"21"
] | Neuropathic pain can develop through various mechanisms, such as a large increase in spontaneous (ectopic) discharges in dorsal root ganglia cell bodies and injured afferent fibers, cross excitation, damage to the high-threshold nociceptors (peripheral sensitization), collateral sprouting of intact fibers into denervat... | true | true | false | true | false | 7,596 |
1 | DISCUSSION | 1 | 22 | [
"B21",
"B22",
"B23",
"B24"
] | 20,830,261 | pmid-1589245|pmid-2812843|pmid-6656869|pmid-7104735 | [22], amplification of the excitability of neurons within the CNS (central sensitization) | [
"21",
"22",
"23",
"24"
] | 89 | 43,936 | 1 | false | , amplification of the excitability of neurons within the CNS (central sensitization) | [
"22"
] | , amplification of the excitability of neurons within the CNS (central sensitization) | false | false | false | true | false | 7,596 |
1 | DISCUSSION | 1 | 23 | [
"B21",
"B22",
"B23",
"B24"
] | 20,830,261 | pmid-1589245|pmid-2812843|pmid-6656869|pmid-7104735 | [23], and central disinhibition due to the loss of an inhibitory mechanism [24]. | [
"21",
"22",
"23",
"24"
] | 80 | 43,937 | 1 | false | , and central disinhibition due to the loss of an inhibitory mechanism. | [
"23",
"24"
] | , and central disinhibition due to the loss of an inhibitory mechanism. | false | false | true | true | false | 7,596 |
2 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | Administration of local anesthetics into the skin before making an incision has been demonstrated to reduce post-operative pain in many kinds of elective surgery, such as inguinal herniorrhaphy | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 193 | 43,938 | 0 | false | Administration of local anesthetics into the skin before making an incision has been demonstrated to reduce post-operative pain in many kinds of elective surgery, such as inguinal herniorrhaphy | [] | Administration of local anesthetics into the skin before making an incision has been demonstrated to reduce post-operative pain in many kinds of elective surgery, such as inguinal herniorrhaphy | true | true | false | true | false | 7,597 |
2 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | [25], tonsillectomy [26], diagnostic laparoscopic procedures [27], gynecological procedure [28] and some orthopedic procedure [29]. | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 131 | 43,939 | 1 | false | , tonsillectomy, diagnostic laparoscopic procedures, gynecological procedure and some orthopedic procedure. | [
"25",
"26",
"27",
"28",
"29"
] | , tonsillectomy, diagnostic laparoscopic procedures, gynecological procedure and some orthopedic procedure. | false | false | true | true | false | 7,597 |
2 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | In studies assessing the use of bupivacaine for reducing postoperative pain, Gordon et al. | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 90 | 43,940 | 0 | false | In studies assessing the use of bupivacaine for reducing postoperative pain, Gordon et al. | [] | In studies assessing the use of bupivacaine for reducing postoperative pain, Gordon et al. | true | true | true | true | true | 7,597 |
2 | DISCUSSION | 1 | 30 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | concluded that the observed blockade of sensory input extended beyond the local anesthetic duration of action [30]. | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 115 | 43,941 | 1 | false | concluded that the observed blockade of sensory input extended beyond the local anesthetic duration of action. | [
"30"
] | concluded that the observed blockade of sensory input extended beyond the local anesthetic duration of action. | false | true | true | true | false | 7,597 |
2 | DISCUSSION | 1 | 25 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | They also suggested that the blockade of nociceptive input by a long-acting local anesthetic may decrease the development of central hyperexcitability, resulting in less pain and reducing the need for additional analgesics. | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 223 | 43,942 | 0 | false | They also suggested that the blockade of nociceptive input by a long-acting local anesthetic may decrease the development of central hyperexcitability, resulting in less pain and reducing the need for additional analgesics. | [] | They also suggested that the blockade of nociceptive input by a long-acting local anesthetic may decrease the development of central hyperexcitability, resulting in less pain and reducing the need for additional analgesics. | true | true | true | true | true | 7,597 |
2 | DISCUSSION | 1 | 31 | [
"B25",
"B26",
"B27",
"B28",
"B29",
"B30",
"B31"
] | 20,830,261 | pmid-2297102|pmid-1784501|pmid-10741813|pmid-8694322|pmid-3419836|pmid-9150295|pmid-9864591 | In our study, we used 0.4% bupivacaine as the local anesthetic for preemptive analgesia because it has a longer half-life than lidocaine and offers potential advantages for the relief of postoperative pain [31]. | [
"25",
"26",
"27",
"28",
"29",
"30",
"31"
] | 211 | 43,943 | 1 | false | In our study, we used 0.4% bupivacaine as the local anesthetic for preemptive analgesia because it has a longer half-life than lidocaine and offers potential advantages for the relief of postoperative pain. | [
"31"
] | In our study, we used 0.4% bupivacaine as the local anesthetic for preemptive analgesia because it has a longer half-life than lidocaine and offers potential advantages for the relief of postoperative pain. | true | true | true | true | true | 7,597 |
3 | DISCUSSION | 1 | 32 | [
"B32",
"B34"
] | 20,830,261 | pmid-15329619|pmid-14639156 | Unlike in other studies [32-34], preemptive bupivacaine did not prevent a decrease in withdrawal thresholds early on, however it did increase thresholds after POD 9 in this study. | [
"32",
"34"
] | 179 | 43,944 | 0 | false | Unlike in other studies, preemptive bupivacaine did not prevent a decrease in withdrawal thresholds early on, however it did increase thresholds after POD 9 in this study. | [
"32-34"
] | Unlike in other studies, preemptive bupivacaine did not prevent a decrease in withdrawal thresholds early on, however it did increase thresholds after POD 9 in this study. | true | true | true | true | true | 7,598 |
3 | DISCUSSION | 1 | 32 | [
"B32",
"B34"
] | 20,830,261 | pmid-15329619|pmid-14639156 | Although the exact mechanism is unknown, possible reasons for this discrepancy may be differences in pain models and/or the method of drug administration. | [
"32",
"34"
] | 154 | 43,945 | 0 | false | Although the exact mechanism is unknown, possible reasons for this discrepancy may be differences in pain models and/or the method of drug administration. | [] | Although the exact mechanism is unknown, possible reasons for this discrepancy may be differences in pain models and/or the method of drug administration. | true | true | true | true | true | 7,598 |
3 | DISCUSSION | 1 | 32 | [
"B32",
"B34"
] | 20,830,261 | pmid-15329619|pmid-14639156 | Judging from this result, infiltrated local anesthetics before nerve injury may not decrease postoperative pain, but may prevent the development of chronic neuropathic pain. | [
"32",
"34"
] | 173 | 43,946 | 0 | false | Judging from this result, infiltrated local anesthetics before nerve injury may not decrease postoperative pain, but may prevent the development of chronic neuropathic pain. | [] | Judging from this result, infiltrated local anesthetics before nerve injury may not decrease postoperative pain, but may prevent the development of chronic neuropathic pain. | true | true | true | true | true | 7,598 |
4 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | In addition to their anti-inflammatory action, steroids have other effects that contribute to their analgesic effect, including acting as reversible local anesthetics, stabilizing neural membranes, inhibiting neural peptide synthesis or action, suppressing ongoing or ectopic neural discharge and inhibiting sensitizatio... | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 350 | 43,947 | 1 | false | In addition to their anti-inflammatory action, steroids have other effects that contribute to their analgesic effect, including acting as reversible local anesthetics, stabilizing neural membranes, inhibiting neural peptide synthesis or action, suppressing ongoing or ectopic neural discharge and inhibiting sensitizatio... | [
"35"
] | In addition to their anti-inflammatory action, steroids have other effects that contribute to their analgesic effect, including acting as reversible local anesthetics, stabilizing neural membranes, inhibiting neural peptide synthesis or action, suppressing ongoing or ectopic neural discharge and inhibiting sensitizatio... | true | true | true | true | true | 7,599 |
4 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | Preoperative use of dexamethasone has been demonstrated to decrease postoperative pain in tonsillectomy, lumbar discectomy, laparoscopic cholecystectomy, and third molar teeth extraction [36-39]. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 195 | 43,948 | 0 | false | Preoperative use of dexamethasone has been demonstrated to decrease postoperative pain in tonsillectomy, lumbar discectomy, laparoscopic cholecystectomy, and third molar teeth extraction. | [
"36-39"
] | Preoperative use of dexamethasone has been demonstrated to decrease postoperative pain in tonsillectomy, lumbar discectomy, laparoscopic cholecystectomy, and third molar teeth extraction. | true | true | true | true | true | 7,599 |
4 | DISCUSSION | 1 | 40 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | According to another report [40], the addition of dexamethasone (8 mg) to a lidocaine (1.5%) solution for axillary brachial plexus block resulted in a significant increase in the duration of sensory and motor blocks, however the onsets of sensory and motor blockade were similar. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 279 | 43,949 | 1 | false | According to another report, the addition of dexamethasone (8 mg) to a lidocaine (1.5%) solution for axillary brachial plexus block resulted in a significant increase in the duration of sensory and motor blocks, however the onsets of sensory and motor blockade were similar. | [
"40"
] | According to another report, the addition of dexamethasone (8 mg) to a lidocaine (1.5%) solution for axillary brachial plexus block resulted in a significant increase in the duration of sensory and motor blocks, however the onsets of sensory and motor blockade were similar. | true | true | true | true | true | 7,599 |
4 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | Devor et al. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 12 | 43,950 | 0 | false | Devor et al. | [] | Devor et al. | true | true | true | true | true | 7,599 |
4 | DISCUSSION | 1 | 41 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | reported corticosteroids may have a local anesthetic effect on the nerve [41]. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 78 | 43,951 | 1 | false | reported corticosteroids may have a local anesthetic effect on the nerve. | [
"41"
] | reported corticosteroids may have a local anesthetic effect on the nerve. | false | true | true | true | false | 7,599 |
4 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | Furthermore, Movafegh et al. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 28 | 43,952 | 0 | false | Furthermore, Movafegh et al. | [] | Furthermore, Movafegh et al. | true | true | true | true | true | 7,599 |
4 | DISCUSSION | 1 | 40 | [
"B35",
"B36",
"B39",
"B40",
"B41",
"B40"
] | 20,830,261 | pmid-16902669|pmid-8250191|pmid-8894809|pmid-16368840|pmid-4047699|pmid-16368840 | suggested the additive effect of dexamethasone and lidocaine for axillary brachial plexus block may be related to this local anesthetic action [40]. | [
"35",
"36",
"39",
"40",
"41",
"40"
] | 148 | 43,953 | 1 | false | suggested the additive effect of dexamethasone and lidocaine for axillary brachial plexus block may be related to this local anesthetic action. | [
"40"
] | suggested the additive effect of dexamethasone and lidocaine for axillary brachial plexus block may be related to this local anesthetic action. | false | true | true | true | false | 7,599 |
5 | DISCUSSION | 1 | 41 | [
"B41"
] | 20,830,261 | pmid-4047699 | Investigation of preemptive administration with bupivacaine or bupivacaine-methylprednisolone to the paravertebral muscles in patients undergoing lumbar discectomy revealed that pain decreased immediately after operation, and investigators asserted that injected corticosteroids acted against pain by inhibiting inflamma... | [
"41"
] | 409 | 43,954 | 1 | false | Investigation of preemptive administration with bupivacaine or bupivacaine-methylprednisolone to the paravertebral muscles in patients undergoing lumbar discectomy revealed that pain decreased immediately after operation, and investigators asserted that injected corticosteroids acted against pain by inhibiting inflamma... | [
"41"
] | Investigation of preemptive administration with bupivacaine or bupivacaine-methylprednisolone to the paravertebral muscles in patients undergoing lumbar discectomy revealed that pain decreased immediately after operation, and investigators asserted that injected corticosteroids acted against pain by inhibiting inflamma... | true | true | true | true | true | 7,600 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | In addition to pain relief in postoperative patients, corticosteroids may suppress neuropathic pain. | [
"42",
"43",
"44",
"45"
] | 100 | 43,955 | 0 | false | In addition to pain relief in postoperative patients, corticosteroids may suppress neuropathic pain. | [] | In addition to pain relief in postoperative patients, corticosteroids may suppress neuropathic pain. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | Large-dose oral glucocorticoids have been demonstrated to alleviate pain, hyperalgesia, and edema in complex regional pain syndrome patients [42]. | [
"42",
"43",
"44",
"45"
] | 146 | 43,956 | 1 | false | Large-dose oral glucocorticoids have been demonstrated to alleviate pain, hyperalgesia, and edema in complex regional pain syndrome patients. | [
"42"
] | Large-dose oral glucocorticoids have been demonstrated to alleviate pain, hyperalgesia, and edema in complex regional pain syndrome patients. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | Kozin et al. | [
"42",
"43",
"44",
"45"
] | 12 | 43,957 | 0 | false | Kozin et al. | [] | Kozin et al. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 43 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | suggested that oral glucocorticoids exerted a prolonged effect even after discontinuation [43]. | [
"42",
"43",
"44",
"45"
] | 95 | 43,958 | 1 | false | suggested that oral glucocorticoids exerted a prolonged effect even after discontinuation. | [
"43"
] | suggested that oral glucocorticoids exerted a prolonged effect even after discontinuation. | false | true | true | true | false | 7,601 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | Furthermore, Kingery et al. | [
"42",
"43",
"44",
"45"
] | 27 | 43,959 | 0 | false | Furthermore, Kingery et al. | [] | Furthermore, Kingery et al. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 44 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | [44] found that continuous infusion of methylprednisolone (3 mg/kg/d for 21 days), initiated after the development of neuropathic hyperalgesia, gradually reversed both heat and mechanical hyperalgesia over a period of several weeks, and an antihyperalgesic effect persisted for at least a week after discontinuing infusi... | [
"42",
"43",
"44",
"45"
] | 323 | 43,960 | 1 | false | found that continuous infusion of methylprednisolone (3 mg/kg/d for 21 days), initiated after the development of neuropathic hyperalgesia, gradually reversed both heat and mechanical hyperalgesia over a period of several weeks, and an antihyperalgesic effect persisted for at least a week after discontinuing infusion. | [
"44"
] | found that continuous infusion of methylprednisolone (3 mg/kg/d for 21 days), initiated after the development of neuropathic hyperalgesia, gradually reversed both heat and mechanical hyperalgesia over a period of several weeks, and an antihyperalgesic effect persisted for at least a week after discontinuing infusion. | false | true | true | true | false | 7,601 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | They also showed that continuous methylprednisolone infusion partially reversed nerve injury-evoked Fos protein expression in the dorsal horns, suggesting that glucocorticoids can inhibit spinal neuron hyperactivity induced by chronic sciatic nerve transaction. | [
"42",
"43",
"44",
"45"
] | 261 | 43,961 | 0 | false | They also showed that continuous methylprednisolone infusion partially reversed nerve injury-evoked Fos protein expression in the dorsal horns, suggesting that glucocorticoids can inhibit spinal neuron hyperactivity induced by chronic sciatic nerve transaction. | [] | They also showed that continuous methylprednisolone infusion partially reversed nerve injury-evoked Fos protein expression in the dorsal horns, suggesting that glucocorticoids can inhibit spinal neuron hyperactivity induced by chronic sciatic nerve transaction. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 45 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | Topical injection of betamethasone has also been shown to inhibit the development of neuropathic pain in a rat model of spinal nerve transaction [45]. | [
"42",
"43",
"44",
"45"
] | 150 | 43,962 | 1 | false | Topical injection of betamethasone has also been shown to inhibit the development of neuropathic pain in a rat model of spinal nerve transaction. | [
"45"
] | Topical injection of betamethasone has also been shown to inhibit the development of neuropathic pain in a rat model of spinal nerve transaction. | true | true | true | true | true | 7,601 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43",
"B44",
"B45"
] | 20,830,261 | pmid-6763435|pmid-56891|pmid-11159254|pmid-16501235 | Betamethasone administration reduced the elevations of NF-κB, TNF-α, and IL-1β, and induced the expression of IL-10 in the brain, all of which were coincident with pain behavior in rats, suggesting that betamethasone may produce analgesic effects by modulating NF-κB and specific cytokines. | [
"42",
"43",
"44",
"45"
] | 290 | 43,963 | 0 | false | Betamethasone administration reduced the elevations of NF-κB, TNF-α, and IL-1β, and induced the expression of IL-10 in the brain, all of which were coincident with pain behavior in rats, suggesting that betamethasone may produce analgesic effects by modulating NF-κB and specific cytokines. | [] | Betamethasone administration reduced the elevations of NF-κB, TNF-α, and IL-1β, and induced the expression of IL-10 in the brain, all of which were coincident with pain behavior in rats, suggesting that betamethasone may produce analgesic effects by modulating NF-κB and specific cytokines. | true | true | true | true | true | 7,601 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | Consistent with these previous observations, the results of our study suggest that dexamethasone may inhibit neuropathic pain through a combination of its prolonged analgesic action and the increased effect of its local anesthetic action with that of bupivacaine. | [
"42"
] | 263 | 43,964 | 0 | false | Consistent with these previous observations, the results of our study suggest that dexamethasone may inhibit neuropathic pain through a combination of its prolonged analgesic action and the increased effect of its local anesthetic action with that of bupivacaine. | [] | Consistent with these previous observations, the results of our study suggest that dexamethasone may inhibit neuropathic pain through a combination of its prolonged analgesic action and the increased effect of its local anesthetic action with that of bupivacaine. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | However, dexamethasone itself had no preemptive anti-neuropathic effect in our study. | [
"42"
] | 85 | 43,965 | 0 | false | However, dexamethasone itself had no preemptive anti-neuropathic effect in our study. | [] | However, dexamethasone itself had no preemptive anti-neuropathic effect in our study. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | This may be due to the small sample sizes (group 2: n = 10, group 5: n = 10). | [
"42"
] | 77 | 43,966 | 0 | false | This may be due to the small sample sizes (group 2: n = 10, group 5: n = 10). | [] | This may be due to the small sample sizes. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | It is also difficult to compare this result with those of other studies because of differences in pain models and method of drug administration. | [
"42"
] | 144 | 43,967 | 0 | false | It is also difficult to compare this result with those of other studies because of differences in pain models and method of drug administration. | [] | It is also difficult to compare this result with those of other studies because of differences in pain models and method of drug administration. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | Clinically, the usual infiltration dosage is from 5-40 ml in 0.25-0.5% bupivacaine. | [
"42"
] | 83 | 43,968 | 0 | false | Clinically, the usual infiltration dosage is from 5-40 ml in 0.25-0.5% bupivacaine. | [] | Clinically, the usual infiltration dosage is from 5-40 ml in 0.25-0.5% bupivacaine. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | Intravenous dosage of dexamethasone is 0.15-3 mg/kg and 8 mg of dexamethasone mixed with 1.5% lidocaine 34 ml was infiltrated via axillary brachial plexus blockade [42]. | [
"42"
] | 169 | 43,969 | 1 | false | Intravenous dosage of dexamethasone is 0.15-3 mg/kg and 8 mg of dexamethasone mixed with 1.5% lidocaine 34 ml was infiltrated via axillary brachial plexus blockade. | [
"42"
] | Intravenous dosage of dexamethasone is 0.15-3 mg/kg and 8 mg of dexamethasone mixed with 1.5% lidocaine 34 ml was infiltrated via axillary brachial plexus blockade. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | The dosage of dexamethasone (0.8 mg) used in this study wasn't small as a single bolus dose for an antineuropathic effect (e.g., through antihyperalgesic action). | [
"42"
] | 162 | 43,970 | 0 | false | The dosage of dexamethasone (0.8 mg) used in this study wasn't small as a single bolus dose for an antineuropathic effect (e.g., through antihyperalgesic action). | [] | The dosage of dexamethasone (0.8 mg) used in this study wasn't small as a single bolus dose for an antineuropathic effect (e.g., through antihyperalgesic action). | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | However, if the single bolus dosage is increased or continuous infusion is performed, dexamethasone could be effective in preventing the development of mechanical allodynia. | [
"42"
] | 173 | 43,971 | 0 | false | However, if the single bolus dosage is increased or continuous infusion is performed, dexamethasone could be effective in preventing the development of mechanical allodynia. | [] | However, if the single bolus dosage is increased or continuous infusion is performed, dexamethasone could be effective in preventing the development of mechanical allodynia. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | Therefore, it is difficult to conclude that the administration of dexamethasone alone has no preemptive analgesic effect in the present study. | [
"42"
] | 142 | 43,972 | 0 | false | Therefore, it is difficult to conclude that the administration of dexamethasone alone has no preemptive analgesic effect in the present study. | [] | Therefore, it is difficult to conclude that the administration of dexamethasone alone has no preemptive analgesic effect in the present study. | true | true | true | true | true | 7,602 |
7 | DISCUSSION | 1 | 42 | [
"B42"
] | 20,830,261 | pmid-6763435 | Taken together, we suggest that the administration of dexamethasone in combination with bupivacaine increases the antiallodynic effect. | [
"42"
] | 135 | 43,973 | 0 | false | Taken together, we suggest that the administration of dexamethasone in combination with bupivacaine increases the antiallodynic effect. | [] | Taken together, we suggest that the administration of dexamethasone in combination with bupivacaine increases the antiallodynic effect. | true | true | true | true | true | 7,602 |
8 | DISCUSSION | 0 | null | null | 20,830,261 | null | The analgesic effect of preoperative infiltration with both bupivacaine and dexamethasone was significantly better than with preoperative infiltration with bupivacaine alone for only the first 9 days after surgery. | null | 214 | 43,974 | 0 | false | null | null | The analgesic effect of preoperative infiltration with both bupivacaine and dexamethasone was significantly better than with preoperative infiltration with bupivacaine alone for only the first 9 days after surgery. | true | true | true | true | true | 7,603 |
8 | DISCUSSION | 0 | null | null | 20,830,261 | null | After 12 days post-surgery, there were no significant differences between preoperative infiltration with bupivacaine-dexamethasone and bupivacaine alone. | null | 153 | 43,975 | 0 | false | null | null | After 12 days post-surgery, there were no significant differences between preoperative infiltration with bupivacaine-dexamethasone and bupivacaine alone. | true | true | true | true | true | 7,603 |
8 | DISCUSSION | 0 | null | null | 20,830,261 | null | In the present study, as in earlier studies, bupivacaine had an apparent preemptive analgesic effect when used alone, but was less effective than the combined analgesic action of bupivacaine and dexamethasone, especially early after injury. | null | 240 | 43,976 | 0 | false | null | null | In the present study, as in earlier studies, bupivacaine had an apparent preemptive analgesic effect when used alone, but was less effective than the combined analgesic action of bupivacaine and dexamethasone, especially early after injury. | true | true | true | true | true | 7,603 |
8 | DISCUSSION | 0 | null | null | 20,830,261 | null | The mechanism of these results is unclear, but it can be postulated that it arises from the anti-inflammatory effect of dexamethasone. | null | 134 | 43,977 | 0 | false | null | null | The mechanism of these results is unclear, but it can be postulated that it arises from the anti-inflammatory effect of dexamethasone. | true | true | true | true | true | 7,603 |
9 | DISCUSSION | 0 | null | null | 20,830,261 | null | In conclusion, preoperative infiltration of both dexamethasone and bupivacaine showed a significantly better analgesic effect than did infiltration of bupivacaine or dexamethasone alone in an SNI model, especially at the early stage after surgery. | null | 247 | 43,978 | 0 | false | null | null | In conclusion, preoperative infiltration of both dexamethasone and bupivacaine showed a significantly better analgesic effect than did infiltration of bupivacaine or dexamethasone alone in an SNI model, especially at the early stage after surgery. | true | true | true | true | true | 7,604 |
9 | DISCUSSION | 0 | null | null | 20,830,261 | null | These results may indicate that dexamethasone acts synergistically or additively with bupivacaine to exert a preemptive analgesic effect, but has no preemptive analgesic effect on its own. | null | 188 | 43,979 | 0 | false | null | null | These results may indicate that dexamethasone acts synergistically or additively with bupivacaine to exert a preemptive analgesic effect, but has no preemptive analgesic effect on its own. | true | true | true | true | true | 7,604 |
9 | DISCUSSION | 0 | null | null | 20,830,261 | null | Finally, preemptive analgesia with local anesthetics alone may be associated with a long-lasting decrease in mechanical allodynia. | null | 130 | 43,980 | 0 | false | null | null | Finally, preemptive analgesia with local anesthetics alone may be associated with a long-lasting decrease in mechanical allodynia. | true | true | true | true | true | 7,604 |
0 | DISCUSSION | 1 | 31 | [
"bib31",
"bib32",
"bib33"
] | 18,039,949 | pmid-16914706|pmid-16126996|pmid-16884970 | This study contains new information that informs two separate but related topics: the therapeutic mechanisms of the TNF inhibitor etanercept, and the network of inflammatory cytokines and leukocytes that drive psoriasis pathogenesis. | [
"31",
"32",
"33"
] | 233 | 43,981 | 0 | false | This study contains new information that informs two separate but related topics: the therapeutic mechanisms of the TNF inhibitor etanercept, and the network of inflammatory cytokines and leukocytes that drive psoriasis pathogenesis. | [] | This study contains new information that informs two separate but related topics: the therapeutic mechanisms of the TNF inhibitor etanercept, and the network of inflammatory cytokines and leukocytes that drive psoriasis pathogenesis. | true | true | true | true | true | 7,605 |
0 | DISCUSSION | 1 | 31 | [
"bib31",
"bib32",
"bib33"
] | 18,039,949 | pmid-16914706|pmid-16126996|pmid-16884970 | Presently, there are three TNF inhibitors in widespread use for the treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, IBD, and ankylosing spondylitis: infliximab and adalimumab, which are monoclonal TNF antibodies, and etanercept, which is a dimeric TNFRII Fc fusion protein (31, 32). | [
"31",
"32",
"33"
] | 301 | 43,982 | 0 | false | Presently, there are three TNF inhibitors in widespread use for the treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, IBD, and ankylosing spondylitis: infliximab and adalimumab, which are monoclonal TNF antibodies, and etanercept, which is a dimeric TNFRII Fc fusion protein. | [
"31, 32"
] | Presently, there are three TNF inhibitors in widespread use for the treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, IBD, and ankylosing spondylitis: infliximab and adalimumab, which are monoclonal TNF antibodies, and etanercept, which is a dimeric TNFRII Fc fusion protein. | true | true | true | true | true | 7,605 |
0 | DISCUSSION | 1 | 33 | [
"bib31",
"bib32",
"bib33"
] | 18,039,949 | pmid-16914706|pmid-16126996|pmid-16884970 | Although often considered as a therapeutic class, these agents are structurally different, have different affinities for TNF, and are not uniformly effective for all inflammatory diseases (33). | [
"31",
"32",
"33"
] | 193 | 43,983 | 1 | false | Although often considered as a therapeutic class, these agents are structurally different, have different affinities for TNF, and are not uniformly effective for all inflammatory diseases. | [
"33"
] | Although often considered as a therapeutic class, these agents are structurally different, have different affinities for TNF, and are not uniformly effective for all inflammatory diseases. | true | true | true | true | true | 7,605 |
0 | DISCUSSION | 1 | 31 | [
"bib31",
"bib32",
"bib33"
] | 18,039,949 | pmid-16914706|pmid-16126996|pmid-16884970 | Although more than one million patients have been treated with these drugs, there are surprisingly little data on therapeutic mechanisms in human inflammatory diseases. | [
"31",
"32",
"33"
] | 168 | 43,984 | 0 | false | Although more than one million patients have been treated with these drugs, there are surprisingly little data on therapeutic mechanisms in human inflammatory diseases. | [] | Although more than one million patients have been treated with these drugs, there are surprisingly little data on therapeutic mechanisms in human inflammatory diseases. | true | true | true | true | true | 7,605 |
0 | DISCUSSION | 1 | 31 | [
"bib31",
"bib32",
"bib33"
] | 18,039,949 | pmid-16914706|pmid-16126996|pmid-16884970 | In this paper, we show that psoriasis disease improvement correlated with early reduction in DC and Th17 cell products and downstream effector molecules, and final disease resolution correlated with late down-modulation of Th1 cells. | [
"31",
"32",
"33"
] | 233 | 43,985 | 0 | false | In this paper, we show that psoriasis disease improvement correlated with early reduction in DC and Th17 cell products and downstream effector molecules, and final disease resolution correlated with late down-modulation of Th1 cells. | [] | In this paper, we show that psoriasis disease improvement correlated with early reduction in DC and Th17 cell products and downstream effector molecules, and final disease resolution correlated with late down-modulation of Th1 cells. | true | true | true | true | true | 7,605 |
1 | DISCUSSION | 1 | 34 | [
"bib34",
"bib35",
"bib36"
] | 18,039,949 | pmid-11677207|pmid-15691299|pmid-17010737 | When considering previous research on the TNF inhibitor mechanism, it is useful to divide response into early (hours to days) versus late (weeks to months) effects. | [
"34",
"35",
"36"
] | 164 | 43,986 | 0 | false | When considering previous research on the TNF inhibitor mechanism, it is useful to divide response into early (hours to days) versus late (weeks to months) effects. | [] | When considering previous research on the TNF inhibitor mechanism, it is useful to divide response into early (hours to days) versus late (weeks to months) effects. | true | true | true | true | true | 7,606 |
1 | DISCUSSION | 1 | 34 | [
"bib34",
"bib35",
"bib36"
] | 18,039,949 | pmid-11677207|pmid-15691299|pmid-17010737 | In the case of infliximab and adalimumab, there are studies suggesting that broad apoptosis of inflammatory leukocytes is induced within hours of drug delivery (34, 35). | [
"34",
"35",
"36"
] | 169 | 43,987 | 0 | false | In the case of infliximab and adalimumab, there are studies suggesting that broad apoptosis of inflammatory leukocytes is induced within hours of drug delivery. | [
"34, 35"
] | In the case of infliximab and adalimumab, there are studies suggesting that broad apoptosis of inflammatory leukocytes is induced within hours of drug delivery. | true | true | true | true | true | 7,606 |
1 | DISCUSSION | 1 | 34 | [
"bib34",
"bib35",
"bib36"
] | 18,039,949 | pmid-11677207|pmid-15691299|pmid-17010737 | With these agents, the reduction of cytokine-driven inflammation is likely a combination of inhibition of TNF-dependent cytokine production, as well as reducing cytokine-producing cells via apoptosis. | [
"34",
"35",
"36"
] | 200 | 43,988 | 0 | false | With these agents, the reduction of cytokine-driven inflammation is likely a combination of inhibition of TNF-dependent cytokine production, as well as reducing cytokine-producing cells via apoptosis. | [] | With these agents, the reduction of cytokine-driven inflammation is likely a combination of inhibition of TNF-dependent cytokine production, as well as reducing cytokine-producing cells via apoptosis. | true | true | true | true | true | 7,606 |
1 | DISCUSSION | 1 | 34 | [
"bib34",
"bib35",
"bib36"
] | 18,039,949 | pmid-11677207|pmid-15691299|pmid-17010737 | Early apoptosis, however, is not a feature of etanercept treatment. | [
"34",
"35",
"36"
] | 67 | 43,989 | 0 | false | Early apoptosis, however, is not a feature of etanercept treatment. | [] | Early apoptosis, however, is not a feature of etanercept treatment. | true | true | true | true | true | 7,606 |
1 | DISCUSSION | 1 | 36 | [
"bib34",
"bib35",
"bib36"
] | 18,039,949 | pmid-11677207|pmid-15691299|pmid-17010737 | Experiments on psoriasis lesions show some leukocyte apoptosis after 1 mo of treatment (36), suggesting that apoptosis is a secondary mechanism after growth factor/TNF withdrawal. | [
"34",
"35",
"36"
] | 179 | 43,990 | 1 | false | Experiments on psoriasis lesions show some leukocyte apoptosis after 1 mo of treatment, suggesting that apoptosis is a secondary mechanism after growth factor/TNF withdrawal. | [
"36"
] | Experiments on psoriasis lesions show some leukocyte apoptosis after 1 mo of treatment, suggesting that apoptosis is a secondary mechanism after growth factor/TNF withdrawal. | true | true | true | true | true | 7,606 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | In this paper, we propose that an early mechanism of etanercept is to inhibit inflammatory DC cytokine production and maturation, leading to a reduction in the activity of Th17 cells. | [
"27",
"37",
"30"
] | 183 | 43,991 | 0 | false | In this paper, we propose that an early mechanism of etanercept is to inhibit inflammatory DC cytokine production and maturation, leading to a reduction in the activity of Th17 cells. | [] | In this paper, we propose that an early mechanism of etanercept is to inhibit inflammatory DC cytokine production and maturation, leading to a reduction in the activity of Th17 cells. | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | Recently, a new type of inflammatory myeloid CD11c+ DC was described in psoriasis, the TipDC (27). | [
"27",
"37",
"30"
] | 98 | 43,992 | 1 | false | Recently, a new type of inflammatory myeloid CD11c+ DC was described in psoriasis, the TipDC. | [
"27"
] | Recently, a new type of inflammatory myeloid CD11c+ DC was described in psoriasis, the TipDC. | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 37 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | This cell type was first identified in a mouse model of innate immune response to Listeria monocytogenes infection (37). | [
"27",
"37",
"30"
] | 120 | 43,993 | 1 | false | This cell type was first identified in a mouse model of innate immune response to Listeria monocytogenes infection. | [
"37"
] | This cell type was first identified in a mouse model of innate immune response to Listeria monocytogenes infection. | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 30 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | In a previous clinical trial using etanercept, iNOS mRNA and protein, along with various other DC and T cell inflammatory cytokines and chemokines, were decreased by 1 mo of treatment (the earliest time point in that study) (30). | [
"27",
"37",
"30"
] | 229 | 43,994 | 1 | false | In a previous clinical trial using etanercept, iNOS mRNA and protein, along with various other DC and T cell inflammatory cytokines and chemokines, were decreased by 1 mo of treatment (the earliest time point in that study). | [
"30"
] | In a previous clinical trial using etanercept, iNOS mRNA and protein, along with various other DC and T cell inflammatory cytokines and chemokines, were decreased by 1 mo of treatment (the earliest time point in that study). | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | Our current study uses even earlier time points to recreate the hierarchy of TNF-dependent mediators and separate primary (early) versus secondary (late) responses. | [
"27",
"37",
"30"
] | 164 | 43,995 | 0 | false | Our current study uses even earlier time points to recreate the hierarchy of TNF-dependent mediators and separate primary (early) versus secondary (late) responses. | [] | Our current study uses even earlier time points to recreate the hierarchy of TNF-dependent mediators and separate primary (early) versus secondary (late) responses. | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | We now show that multiple inflammatory products of TipDCs, including iNOS, TNF, IL-20, and IL23 p40 subunit, are reduced within 1–2 wk after beginning etanercept, whereas the number of CD11c+ DCs in the tissue is minimally affected during this time, suggesting an initial blockade of cytokine production by these cells r... | [
"27",
"37",
"30"
] | 346 | 43,996 | 0 | false | We now show that multiple inflammatory products of TipDCs, including iNOS, TNF, IL-20, and IL23 p40 subunit, are reduced within 1–2 wk after beginning etanercept, whereas the number of CD11c+ DCs in the tissue is minimally affected during this time, suggesting an initial blockade of cytokine production by these cells r... | [] | We now show that multiple inflammatory products of TipDCs, including iNOS, TNF, IL-20, and IL23 p40 subunit, are reduced within 1–2 wk after beginning etanercept, whereas the number of CD11c+ DCs in the tissue is minimally affected during this time, suggesting an initial blockade of cytokine production by these cells r... | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | This suggests that TNF is an autocrine or paracrine inducer of TipDC inflammatory products that is blocked by etanercept. | [
"27",
"37",
"30"
] | 121 | 43,997 | 0 | false | This suggests that TNF is an autocrine or paracrine inducer of TipDC inflammatory products that is blocked by etanercept. | [] | This suggests that TNF is an autocrine or paracrine inducer of TipDC inflammatory products that is blocked by etanercept. | true | true | true | true | true | 7,607 |
2 | DISCUSSION | 1 | 27 | [
"bib27",
"bib37",
"bib30"
] | 18,039,949 | pmid-14707118|pmid-12871639|pmid-16081850 | This direct effect on DCs is supported by our in vitro studies with MoDCs showing that etanercept blocked up-regulation of co-stimulatory and MHC class II molecules, IL-23 production, and immunostimulatory capacity. | [
"27",
"37",
"30"
] | 215 | 43,998 | 0 | false | This direct effect on DCs is supported by our in vitro studies with MoDCs showing that etanercept blocked up-regulation of co-stimulatory and MHC class II molecules, IL-23 production, and immunostimulatory capacity. | [] | This direct effect on DCs is supported by our in vitro studies with MoDCs showing that etanercept blocked up-regulation of co-stimulatory and MHC class II molecules, IL-23 production, and immunostimulatory capacity. | true | true | true | true | true | 7,607 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | The early modulation of TipDCs by etanercept may rapidly affect Th17 cells, beginning the process of molecular resolution before reduction in cellular infiltrates and long before clinical resolution. | [
"38",
"7"
] | 199 | 43,999 | 0 | false | The early modulation of TipDCs by etanercept may rapidly affect Th17 cells, beginning the process of molecular resolution before reduction in cellular infiltrates and long before clinical resolution. | [] | The early modulation of TipDCs by etanercept may rapidly affect Th17 cells, beginning the process of molecular resolution before reduction in cellular infiltrates and long before clinical resolution. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | Our proposed psoriatic inflammatory pathway involves the production of IL-23 from these inflammatory TipDCs causing proliferation of Th17 cells, with subsequent induction of IL-17, IL-22, and other products (Fig. | [
"38",
"7"
] | 212 | 44,000 | 0 | false | Our proposed psoriatic inflammatory pathway involves the production of IL-23 from these inflammatory TipDCs causing proliferation of Th17 cells, with subsequent induction of IL-17, IL-22, and other products (Fig. | [] | Our proposed psoriatic inflammatory pathway involves the production of IL-23 from these inflammatory TipDCs causing proliferation of Th17 cells, with subsequent induction of IL-17, IL-22, and other products (Fig. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | IL-17 appears to serve as an inducer of keratinocytes to produce antimicrobial peptides like DEFB4, S100 acute-phase proteins, and chemokines such as IL-8 (38). | [
"38",
"7"
] | 160 | 44,001 | 1 | false | IL-17 appears to serve as an inducer of keratinocytes to produce antimicrobial peptides like DEFB4, S100 acute-phase proteins, and chemokines such as IL-8. | [
"38"
] | IL-17 appears to serve as an inducer of keratinocytes to produce antimicrobial peptides like DEFB4, S100 acute-phase proteins, and chemokines such as IL-8. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 7 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | Models of psoriasis suggest that IL-22 strongly induces keratinocyte hyperplasia and mediates IL-23–induced dermal inflammation and acanthosis (7). | [
"38",
"7"
] | 147 | 44,002 | 1 | false | Models of psoriasis suggest that IL-22 strongly induces keratinocyte hyperplasia and mediates IL-23–induced dermal inflammation and acanthosis. | [
"7"
] | Models of psoriasis suggest that IL-22 strongly induces keratinocyte hyperplasia and mediates IL-23–induced dermal inflammation and acanthosis. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | All of these products were down-modulated within 1–2 wk of etanercept treatment. | [
"38",
"7"
] | 80 | 44,003 | 0 | false | All of these products were down-modulated within 1–2 wk of etanercept treatment. | [] | All of these products were down-modulated within 1–2 wk of etanercept treatment. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | The involvement of Th17 cells in psoriasis may now help explain the following: hyperplasia of psoriatic keratinocytes (IL-22); why psoriatics are relatively protected from bacterial infection (defensins); and why neutrophils that are normally reserved for acute inflammatory processes appear in a chronic inflammatory di... | [
"38",
"7"
] | 333 | 44,004 | 0 | false | The involvement of Th17 cells in psoriasis may now help explain the following: hyperplasia of psoriatic keratinocytes (IL-22); why psoriatics are relatively protected from bacterial infection (defensins); and why neutrophils that are normally reserved for acute inflammatory processes appear in a chronic inflammatory di... | [] | The involvement of Th17 cells in psoriasis may now help explain the following: hyperplasia of psoriatic keratinocytes (IL-22); why psoriatics are relatively protected from bacterial infection (defensins); and why neutrophils that are normally reserved for acute inflammatory processes appear in a chronic inflammatory di... | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | Moreover, histological resolution of the disease, as defined by decreased epidermal thickness and normalization of keratinocyte proliferation (Ki67) and differentiation (K16), correlates with rapidly decreased TipDC and Th17 cell products. | [
"38",
"7"
] | 239 | 44,005 | 0 | false | Moreover, histological resolution of the disease, as defined by decreased epidermal thickness and normalization of keratinocyte proliferation and differentiation (K16), correlates with rapidly decreased TipDC and Th17 cell products. | [
"Ki67"
] | Moreover, histological resolution of the disease, as defined by decreased epidermal thickness and normalization of keratinocyte proliferation and differentiation (K16), correlates with rapidly decreased TipDC and Th17 cell products. | true | true | true | true | true | 7,608 |
3 | DISCUSSION | 1 | 38 | [
"bib38",
"bib7"
] | 18,039,949 | pmid-15322213|pmid-17187052 | Thus, these results suggest that Th17 cells are important for disease pathogenesis and may be modified by etanercept at an early time point. | [
"38",
"7"
] | 140 | 44,006 | 0 | false | Thus, these results suggest that Th17 cells are important for disease pathogenesis and may be modified by etanercept at an early time point. | [] | Thus, these results suggest that Th17 cells are important for disease pathogenesis and may be modified by etanercept at an early time point. | true | true | true | true | true | 7,608 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null |
Proposed role of Th17 and Th1 cells in psoriasis pathogenesis. | null | 63 | 44,007 | 0 | false | null | null |
Proposed role of Th17 and Th1 cells in psoriasis pathogenesis. | false | false | true | true | false | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | TNF stimulates CD11c+ inflammatory DCs to produce IL-23 and IL-20. | null | 66 | 44,008 | 0 | false | null | null | TNF stimulates CD11c+ inflammatory DCs to produce IL-23 and IL-20. | true | true | true | true | true | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | DC activation and production of IL-23 supports Th17 cell survival and proliferation and induces the production of IL-17 and IL-22. | null | 130 | 44,009 | 0 | false | null | null | DC activation and production of IL-23 supports Th17 cell survival and proliferation and induces the production of IL-17 and IL-22. | true | true | true | true | true | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | DC and Th17 cell products activate keratinocytes, promoting the release of innate inflammatory molecules such as DEFB4, S100A7, and IL-8. | null | 137 | 44,010 | 0 | false | null | null | DC and Th17 cell products activate keratinocytes, promoting the release of innate inflammatory molecules such as DEFB4, S100A7, and IL-8. | true | true | true | true | true | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | Concurrently, Th1 cells producing IFN-γ activate keratinocytes to up-regulate MHC class II molecules (HLA-DR) and integrins (ICAM), and release cytokines including membrane Ig (MIG) and IFN-inducible protein 10 (IP-10). | null | 219 | 44,011 | 0 | false | null | null | Concurrently, Th1 cells producing IFN-γ activate keratinocytes to up-regulate MHC class II molecules (HLA-DR) and integrins (ICAM), and release cytokines including membrane Ig (MIG) and IFN-inducible protein 10 (IP-10). | true | true | true | true | true | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | Th1 and Th17 cells may suppress each other's development, but IFN-γ can also act synergistically with IL-17 to increase ICAM expression and IL-8 release from keratinocytes. | null | 172 | 44,012 | 0 | false | null | null | Th1 and Th17 cells may suppress each other's development, but IFN-γ can also act synergistically with IL-17 to increase ICAM expression and IL-8 release from keratinocytes. | true | true | true | true | true | 7,609 |
4 | DISCUSSION | 0 | null | null | 18,039,949 | null | In psoriasis, etanercept may proximally inhibit this IL-23–IL-17 pathway to normalize keratinocyte proliferation and leukocyte infiltration. | null | 140 | 44,013 | 0 | false | null | null | In psoriasis, etanercept may proximally inhibit this IL-23–IL-17 pathway to normalize keratinocyte proliferation and leukocyte infiltration. | true | true | true | true | true | 7,609 |
5 | DISCUSSION | 1 | 30 | [
"bib30",
"bib39",
"bib40",
"bib41",
"bib42",
"bib15",
"bib43"
] | 18,039,949 | pmid-16081850|pmid-9764847|pmid-17603494|pmid-14678257|pmid-15099362|pmid-16200068|pmid-17307864 | Finally, although there is an emerging role for Th17 cells driving inflammation in psoriasis, Th1 cells may still be important for final disease resolution. | [
"30",
"39",
"40",
"41",
"42",
"15",
"43"
] | 156 | 44,014 | 0 | false | Finally, although there is an emerging role for Th17 cells driving inflammation in psoriasis, Th1 cells may still be important for final disease resolution. | [] | Finally, although there is an emerging role for Th17 cells driving inflammation in psoriasis, Th1 cells may still be important for final disease resolution. | true | true | true | true | true | 7,610 |
5 | DISCUSSION | 1 | 30 | [
"bib30",
"bib39",
"bib40",
"bib41",
"bib42",
"bib15",
"bib43"
] | 18,039,949 | pmid-16081850|pmid-9764847|pmid-17603494|pmid-14678257|pmid-15099362|pmid-16200068|pmid-17307864 | Although TipDC and Th17 cell products are down-modulated within 2 wk of etanercept treatment, IFN-γ is not decreased until week 12, and STAT-1 (an IFN-γ–dependent transcription factor) is not significantly decreased until several months of treatment (30). | [
"30",
"39",
"40",
"41",
"42",
"15",
"43"
] | 255 | 44,015 | 1 | false | Although TipDC and Th17 cell products are down-modulated within 2 wk of etanercept treatment, IFN-γ is not decreased until week 12, and STAT-1 (an IFN-γ–dependent transcription factor) is not significantly decreased until several months of treatment. | [
"30"
] | Although TipDC and Th17 cell products are down-modulated within 2 wk of etanercept treatment, IFN-γ is not decreased until week 12, and STAT-1 (an IFN-γ–dependent transcription factor) is not significantly decreased until several months of treatment. | true | true | true | true | true | 7,610 |
5 | DISCUSSION | 1 | 30 | [
"bib30",
"bib39",
"bib40",
"bib41",
"bib42",
"bib15",
"bib43"
] | 18,039,949 | pmid-16081850|pmid-9764847|pmid-17603494|pmid-14678257|pmid-15099362|pmid-16200068|pmid-17307864 | Therefore, although histological disease resolution begins within weeks, complete remission does not occur until after several months of treatment, when both Th17 and Th1 cell products have been down-modulated. | [
"30",
"39",
"40",
"41",
"42",
"15",
"43"
] | 210 | 44,016 | 0 | false | Therefore, although histological disease resolution begins within weeks, complete remission does not occur until after several months of treatment, when both Th17 and Th1 cell products have been down-modulated. | [] | Therefore, although histological disease resolution begins within weeks, complete remission does not occur until after several months of treatment, when both Th17 and Th1 cell products have been down-modulated. | true | true | true | true | true | 7,610 |
5 | DISCUSSION | 1 | 39 | [
"bib30",
"bib39",
"bib40",
"bib41",
"bib42",
"bib15",
"bib43"
] | 18,039,949 | pmid-16081850|pmid-9764847|pmid-17603494|pmid-14678257|pmid-15099362|pmid-16200068|pmid-17307864 | IFN-γ is a major inducer of MHC class II and acts synergistically with IL-17 to up-regulate keratinocyte intracellular adhesion molecule (ICAM)–1 and IL-8 production (39), suggesting that Th1 cells may be important for leukocyte activation. | [
"30",
"39",
"40",
"41",
"42",
"15",
"43"
] | 240 | 44,017 | 1 | false | IFN-γ is a major inducer of MHC class II and acts synergistically with IL-17 to up-regulate keratinocyte intracellular adhesion molecule (ICAM)–1 and IL-8 production, suggesting that Th1 cells may be important for leukocyte activation. | [
"39"
] | IFN-γ is a major inducer of MHC class II and acts synergistically with IL-17 to up-regulate keratinocyte intracellular adhesion molecule (ICAM)–1 and IL-8 production, suggesting that Th1 cells may be important for leukocyte activation. | true | true | true | true | true | 7,610 |
5 | DISCUSSION | 1 | 40 | [
"bib30",
"bib39",
"bib40",
"bib41",
"bib42",
"bib15",
"bib43"
] | 18,039,949 | pmid-16081850|pmid-9764847|pmid-17603494|pmid-14678257|pmid-15099362|pmid-16200068|pmid-17307864 | Activated T cells are required in the epidermis for psoriasis to develop (40), and most epidermal T cells are type 1 CD8+ cells (41); it follows that they must be ablated for disease resolution. | [
"30",
"39",
"40",
"41",
"42",
"15",
"43"
] | 194 | 44,018 | 1 | false | Activated T cells are required in the epidermis for psoriasis to develop, and most epidermal T cells are type 1 CD8+ cells ; it follows that they must be ablated for disease resolution. | [
"40",
"41"
] | Activated T cells are required in the epidermis for psoriasis to develop, and most epidermal T cells are type 1 CD8+ cells ; it follows that they must be ablated for disease resolution. | true | true | true | true | true | 7,610 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.